Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Federal Trade Commission
Healthtrust
Julphar
Express Scripts
Johnson and Johnson
Deloitte
AstraZeneca
Harvard Business School

Generated: December 11, 2017

DrugPatentWatch Database Preview

VELETRI Drug Profile

« Back to Dashboard

When do Veletri patents expire, and when can generic versions of Veletri launch?

Veletri is a drug marketed by Actelion Pharms Ltd and is included in one NDA. There are two patents protecting this drug.

This drug has eighteen patent family members in fourteen countries.

The generic ingredient in VELETRI is epoprostenol sodium. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the epoprostenol sodium profile page.
Drug patent expirations by year for VELETRI

Pharmacology for VELETRI

Ingredient-typeProstaglandins I
Drug ClassProstacycline Vasodilator
Physiological EffectVasodilation

Medical Subject Heading (MeSH) Categories for VELETRI

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actelion Pharms LtdVELETRIepoprostenol sodiumINJECTABLE;INJECTION022260-002Jun 28, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Actelion Pharms LtdVELETRIepoprostenol sodiumINJECTABLE;INJECTION022260-001Jun 27, 2008RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Actelion Pharms LtdVELETRIepoprostenol sodiumINJECTABLE;INJECTION022260-002Jun 28, 2012RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdVELETRIepoprostenol sodiumINJECTABLE;INJECTION022260-001Jun 27, 2008RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VELETRI

Country Document Number Estimated Expiration
BrazilPI0707488► Subscribe
Canada2641393► Subscribe
China101410119► Subscribe
Japan2009525344► Subscribe
Canada2868998► Subscribe
South Korea101351668► Subscribe
Russian Federation2008135701► Subscribe
Russian Federation2423130► Subscribe
South Korea20090004867► Subscribe
Denmark1993557► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Healthtrust
Moodys
Merck
Daiichi Sankyo
QuintilesIMS
McKinsey
US Army
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot